University Medical Center Hamburg-Eppendorf-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2012

  1. Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: A randomised phase II study

    British Journal of Cancer, Vol. 107, Núm. 3, pp. 435-441